Literature DB >> 15402536

Renal hyperemia induced in man by a new phthalazine derivative.

F C REUBI.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1950        PMID: 15402536     DOI: 10.3181/00379727-73-17591

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  13 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Fixed and reproducible orthostatic proteinuria. III. Effect of induced renal hemodynamic alterations upon urinary protein excretion.

Authors:  R R ROBINSON; F R LECOCQ; P J PHILLIPPI; W G GLENN
Journal:  J Clin Invest       Date:  1963-01       Impact factor: 14.808

3.  Vaso-motor factor in glaucoma.

Authors:  E G MACKIE
Journal:  Br J Ophthalmol       Date:  1958-01       Impact factor: 4.638

4.  Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline).

Authors:  E L WILKINSON; H BACKMAN; H H HECHT
Journal:  J Clin Invest       Date:  1952-10       Impact factor: 14.808

5.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

6.  The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits.

Authors:  B M Johnson
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

7.  Changes in renal function induced by endralazine, a new antihypertensive drug.

Authors:  E Wegmüller; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Mechanism of action of hydralazine and ISF 2123 on arterial smooth muscle [proceedings].

Authors:  M Worcel
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

9.  Cardiovascular and renal responses to the combination of hexamethonium and 1-hydrazinophthalazine (apresoline) in hypertensive subjects.

Authors:  D H STEIN; H H HECHT
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

10.  Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.

Authors:  N S ASSALI; S KAPLAN; S OIGHENSTEIN; R SUYEMOTO
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.